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Abstract – Coronary artery disease (CAD) is the leading cause of death worldwide. Microarray analysis is a practical ap-
proach to study gene transcription changes that may reflect signatures that underlie the pathogenesis of CAD. Using gene 
expression profile data from the Gene Expression Omnibus database, we identified differentially expressed genes that can 
contribute to the pathology of CAD. Further pathway and network analyses were also implemented to identify pathways 
and hub genes related to the disease. We observed 466 downregulated and 560 upregulated genes. The ribosome pathway 
was the most significantly over-represented pathway with differentially expressed genes. Over 35% of the genes in this 
pathway were downregulated. Hub genes in the network, such as IL7R, FYN, CALM1 ESR1 and PLCG1, may play crucial 
roles in the pathogenesis of CAD. Our results facilitate the identification of molecular mechanisms that underlie CAD.
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INTRODUCTION
As the most common type of heart disease, coronary 
artery disease (CAD) is the leading cause of death 
worldwide  (Thomas,  et  al.,  1988).  Most  patients 
show no symptoms or signs of CAD for decades dur-
ing  progression  of  the  disease.  For  most  patients, 
the first onset of symptoms is a sudden heart attack. 
While considerable efforts have been devoted to the 
prevention  and  treatment  of  CAD,  morbidity  and 
mortality remain high. Investigation of the under-
lying molecular mechanism may accelerate further 
investigations into new strategies of noninvasive di-
agnosis and treatment.
Microarray  analysis  is  a  practical  approach  to 
study gene transcription changes that may reflect sig-
natures underlying CAD pathogenesis. Distinct gene 
expression patterns in atherosclerotic diseases have 
been proposed in previous gene expression studies 
(Hiltunen, et al., 2002; Nanni, et al., 2006; Randi, et 
al., 2003; Seo, et al., 2004). Different pathways, such 
as those involved in the inflammatory process and 
cell cycle control, have been consistently identified 
in CAD patients (Cagnin, et al., 2009; Sluimer, et al., 
2007), suggesting that “molecule groups” instead of 
a single or few proteins should be explored while in-
vestigating CAD pathogenesis. Most proteins func-
tion through their interaction with other proteins in 
certain biological pathways. Therefore, analysis from 
the point of view of pathway and network would pro-
vide a better understanding of the mechanisms un-
derlying CAD progression. However, most previous 
efforts have focused on individual genes.
In  this  study,  with  a  gene  expression  data  set 
downloaded  from  the  gene  expression  omnibus 
(GEO)  database,  we  identified  differentially  ex-
pressed genes correlated with CAD. Pathways with 
significantly increased dysregulated genes were also 984 HUI LI ET AL.
acquired. Protein-protein interaction (PPI) network 
analysis was also carried out to identify key genes 
among the differentially expressed genes.
MATERIALS AND METHODS
Microarray data
The transcription profile GSE12288 was downloaded 
from the GEO database (http://www.ncbi.nlm.nih.
gov/geo/). This series represents the gene expression 
profile for 110 CAD patients and 112 controls. The 
data set was based on the GPL96 platform: [HG-
U133A] Affymetrix Human Genome U133A Array.
Identification of differentially expressed genes
Raw intensity values from raw data files were nor-
malized using Robust Multi-array Analysis (RMA) 
(Irizarry, et al., 2003) as follows: i) background noise 
was neutralized by using model-based background 
correction; ii) expression values were normalized 
using  quantile  normalization;  iii)  the  expression 
value for each probe was generated using an itera-
tive median polishing procedure. The log2-trans-
formed RMA values for each subject were stored 
for further identification of significantly differen-
tially expressed genes. Correlation analysis with the 
Benjamini and Hochberg multiple test correction 
(Benjamini and Hochberg, 1995) was carried out 
to detect differentially expressed genes. The thresh-
old was set as 0.01. Up- or downregulation of each 
differentially  expressed  probe  was  expressed  by 
fold change. All the above procedures were carried 
out using R software (v2.15.1) with BioConductor, 
limma packages (3.12.1) and libraries (Smyth, et al., 
2005).
Pathway enrichment analysis
Selected probes were annotated according to the sim-
ple omnibus format in text (SOFT) files. All genes 
were then annotated based on the KEGG pathways 
database  (http://www.genome.jp/kegg/)  (Kanehisa 
and Goto, 2000). Enrichment analysis was carried 
out  using  the  hypergeometric  distribution  test  to 
identify  pathways  enriched  with  differentially  ex-
pressed genes.
Network analysis
Protein-protein interaction (PPI) is critical for bio-
logical  processes  (Stelzl,  et  al.,  2005)  since  most 
proteins  function  through  interactions  with  other 
proteins. To illustrate the relationship between the 
differentially expressed genes, a network was con-
structed by using Cytoscape (V 2.8.3, http://www.
cytoscape.org/) (Shannon, et al., 2003) and the Na-
tional Center for Biotechnology Information (NCBI) 
database  (http://ftp.ncbi.nlm.nih.gov/gene/GeneR-
IF/, 2013-2-25).
RESULTS
We detected 1 026 differentially expressed genes of 
which 466 genes correlated negatively and 560 genes 
correlated positively with CAD.
Of all of the well-characterized human genes in 
the array, 5 298 genes were mapped to various path-
ways, including 447 differentially expressed genes. 
The  top  10  pathways  enriched  with  dysregulated 
genes (Table 1), include two signaling pathways: the 
calcium signaling pathway (hsa04020) and the adi-
pocytokine signaling pathway (hsa04920). The ribos-
ome pathway (hsa03010) was the most significantly 
enriched with differentially expressed genes. Among 
the  119  genes  in  the  ribosome  pathway,  45  genes 
were  negatively  correlated  with  CAD.  The  vascu-
lar smooth muscle contraction pathway (hsa04270) 
and the dilated cardiomyopathy pathway (hsa05414) 
were also significantly dysregulated. 
Fig. 1 illustrates the interactions between pro-
teins encoded by differentially expressed genes. The 
degree of each node is defined as its number of inter-
actions. Nodes with high degrees were considered as 
hubs. Table 2 represents the top five hub nodes with 
degrees higher than 10. Most of them were known to 
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Table 1. Pathways with diff  erentially expressed genes.
KEGG_ID Pathway Description P-value
03010 Ribosome 4.37E-21
04114 Oocyte meiosis 8.18E-04
04740 Olfactory transduction 4.44E-03
00982 Drug metabolism-cytochrome P450 6.42E-03
04020 Calcium signaling pathway 1.51E-02
04920 Adipocytokine signaling pathway 2.09E-02
03040 Spliceosome 2.67E-02
04270 Vascular smooth muscle contraction 3.39E-02
03018 RNA degradation 3.50E-02
05414 Dilated cardiomyopathy (DCM) 4.43E-02
Table 2. Th   e top fi  ve molecules in the network constructed by diff  erentially expressed genes.
Gene Implications in CAD or other heart disorders (PubMed ID) Degree
IL7R Heart disease (20379172) 19
FYN Coronary artery vasculopathy (18336251) 17
CALM1 Coronary artery disease (17569884) 16
ESR1 Coronary artery disease (23471591, 16612467, 16551651) 15
PLCG1 No known association with heart disorders 13
UBA UBAP2 2L
RPS PS3 3 3 3
R R R RPL23 3
RPL23 RPL23A
TNPO TNPO1 1
R RPL12 2
PLXNA PLXNA PLXNA PLXNA PLXNA2 2
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T T T TRHR R
RPL RPL5 5
CCNB CCNB CCNB CCNB1
HBEG HBEG HBEG HBEGF
HG GF F
CDC2 CDC27
ANP32 ANP32B
WBP WBP5 5
LTBP LTBP3 3
EPB41L EPB41L EPB41L EPB41L2
TGFB TGFB2
FKBP FKBP2
DHX DHX DHX DHX DHX9 9
FNBP FNBP FNBP FNBP4 4 4 4 SPTAN SPTAN SPTAN SPTAN SPTAN1 1
PDE4 PDE4 PDE4 PDE4 PDE4D D D D
EPB41L EPB41L3
R R R R R R RP P PL29 9
ARRB ARRB ARRB ARRB1
ILF3
RPS2 RPS2 RPS2 RPS2 RPS20 0 0 0
ME MET T
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Fig. 1. Interaction network of diff  erentially expressed genes. Only genes with more than two direct or indirect links are shown. Genes 
with a higher degree (more links) are shown in bigger size. Genes shown in red are overexpressed while genes in blue are downregu-
lated.986 HUI LI ET AL.
DISCUSSION
The pathophysiology of CAD is highly complex. Here 
we carried out expression profile analysis to identify 
differentially expressed genes in CAD patients and 
healthy controls. Pathway and interaction network 
analyses were also carried out to explore the under-
lying mechanism.
Pathway  analysis  revealed  an  over-representa-
tion of differentially expressed genes in the calcium-
signaling pathway (hsa04020). This is consistent with 
prior knowledge, since Ca2+ plays important roles in 
the regulation of contraction and intracellular sig-
naling, which is crucial for the normal function of 
healthy heart (Cartwright, et al., 2011). Significant 
dysregulation of another two pathways, the vascular 
smooth muscle contraction pathway and the dilated 
cardiomyopathy pathway, also implicated the inter-
ruption of normal heart function in CAD patients. 
The ribosome pathway was most significantly over-
represented with differentially expressed genes. Over 
35% of the genes in this pathway were downregu-
lated. No previous report has proposed the relation-
ship of the ribosome pathway and CAD. However, 
ribosomal RNA expression was revealed to be highly 
variable in CAD patients (Fong et al, 2013). Moreo-
ver, in Drosophila melanogaster, cardiomyopathy is 
associated with ribosomal protein gene haploinsuf-
ficiency (Casad, et al., 2011). Further investigation of 
this pathway on CAD is warranted. 
In  the  constructed  network,  IL7R  showed  the 
highest degree (Fig. 1, Table 2). The protein encoded 
by the IL7R is a receptor of IL-7, which has been as-
sociated with inflammatory processes (Mobini, et al., 
2009). Inflammation has been shown to play cru-
cial pathologic roles in atherosclerosis CAD (Libby,, 
2002). Previous gene expression analysis has also re-
ported the downregulation of IL7R in heart disease 
patients (Lukk, et al., 2010). Our investigation fur-
ther highlights the importance of IL7R in the patho-
genesis of CAD.
FYN was a hub gene with the second highest de-
gree (Fig. 1, Table 2). The protein encoded by this 
gene is a membrane-associated tyrosine kinase that 
has been involved in the control of cell growth. Dif-
ferential expression of cell cycle genes in CAD pa-
tients has been consistently reported (Cagnin, et al., 
2009; Ijas, et al., 2007; Mohler, et al., 2008). The in-
volvement of FYN in the pathogenesis of coronary 
artery vasculopathy through its activation of the T-
cell receptor was observed. Our investigation con-
firms the relationship between FYN and CAD.
CALM1  encodes  a  member  of  the  calcium-
binding  protein  family.  Our  pathway  analysis  has 
highlighted the involvement of the calcium-signal-
ing pathway in the pathogenesis of CAD. Previous 
studies have indicated that a genetic variability of 
CALM1 was associated with CAD (Luke, et al., 2009; 
Luke, et al., 2007). Herein we present evidence for 
the involvement of this gene in CAD. Another hub 
gene is ESR1, which encodes the estrogen receptor. 
Polymorphism of this gene has been associated with 
CAD  in  various  populations  (Almeida  and  Hutz, 
2006; Wei, et al., 2013; Lawlor, et al., 2006). Our in-
vestigation further confirms the involvement of ESR1 
in CAD. PLCG1 was also identified as a hub gene. 
No previous report of the relationship between CAD 
and PLCG1 has been proposed. Further investigation 
should be carried out to confirm its implication in 
the pathogenesis of CAD.
In summary, using gene expression profile data 
from the GEO database we identified differentially 
expressed genes that may contribute to the pathology 
of  CAD.  Significantly  increased  representations  of 
dysregulated genes in the ribosome pathway and cal-
cium signaling pathway were identified. Hub genes in 
the network, such as IL7R, FYN, CALM1 ESR1 and 
PLCG1, could play crucial roles in the pathogenesis 
of CAD. Our results facilitate the identification of the 
molecular mechanism underlying CAD.
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